Shanye Yin

Shanye Yin

Harvard University

H-index: 23

North America-United States

About Shanye Yin

Shanye Yin, With an exceptional h-index of 23 and a recent h-index of 17 (since 2020), a distinguished researcher at Harvard University, specializes in the field of 生物医学.

His recent articles reflect a diverse array of research interests and contributions to the field:

Unveiling neoadjuvant chemotherapy-induced immune landscape remodeling and metabolic reprogramming in lung adenocarcinoma by scRNA-sequencing

Decoding the Pan-Cancer regulatory landscape: Insights from proteogenomics and post-translational modifications

Integrated Immunopeptidomic and Proteomic Analysis of COVID-19 lung biopsies

Targeting conditioned media dependencies and FLT-3 in chronic lymphocytic leukemia

ZNF683 marks a CD8+ T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome

Loss-of-function lesions impact B-cell development and fitness but are insufficient to drive CLL in mouse models

In Vivo Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities

Viral oncogenes, viruses, and cancer: a third-generation sequencing perspective on viral integration into the human genome

Shanye Yin Information

University

Position

Harvard medical school

Citations(all)

1459

Citations(since 2020)

1040

Cited By

821

hIndex(all)

23

hIndex(since 2020)

17

i10Index(all)

25

i10Index(since 2020)

21

Email

University Profile Page

Google Scholar

Shanye Yin Skills & Research Interests

生物医学

Top articles of Shanye Yin

Unveiling neoadjuvant chemotherapy-induced immune landscape remodeling and metabolic reprogramming in lung adenocarcinoma by scRNA-sequencing

bioRxiv

2024

Decoding the Pan-Cancer regulatory landscape: Insights from proteogenomics and post-translational modifications

The Innovation Life

2023/10/30

Wenjun Deng
Wenjun Deng

H-Index: 13

Shanye Yin
Shanye Yin

H-Index: 14

Integrated Immunopeptidomic and Proteomic Analysis of COVID-19 lung biopsies

Frontiers in immunology

2023/10/20

Targeting conditioned media dependencies and FLT-3 in chronic lymphocytic leukemia

Blood Advances

2023/10/10

Shanye Yin
Shanye Yin

H-Index: 14

Anthony Letai
Anthony Letai

H-Index: 64

ZNF683 marks a CD8+ T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome

Cancer cell

2023/10/9

Loss-of-function lesions impact B-cell development and fitness but are insufficient to drive CLL in mouse models

Blood Advances

2023/8/22

In Vivo Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities

Blood cancer discovery

2023/3/1

Viral oncogenes, viruses, and cancer: a third-generation sequencing perspective on viral integration into the human genome

2023

Mitral valve aneurysms: echocardiographic characteristics, formation mechanisms, and patient outcomes

Frontiers in Cardiovascular Medicine

2023

ZNF683 (Hobit) marks a CD8+ T cell population associated with anti-tumor immunity following anti-PD-1 therapy for richter syndrome

Blood

2022/11/15

Abstract A39: Targeting tumor-microenvironmental dependencies as a therapeutic approach in Chronic Lymphocytic Leukemia (CLL)

Blood Cancer Discovery

2022/9/6

Shanye Yin
Shanye Yin

H-Index: 14

Anthony Letai
Anthony Letai

H-Index: 64

Chemokine Receptor 1 and its associated immune pathway are downregulated in SF3B1MT blood and non-blood cancers

bioRxiv

2022/3/31

11. Leucémie lymphoïde chronique

Hématologie

2022/3/30

Activation of Notch and Myc Signaling via B-cell–Restricted Depletion of Dnmt3a Generates a Consistent Murine Model of Chronic Lymphocytic Leukemia

Cancer research

2021/12/15

B Cell-Restricted Depletion of Dnmt3a Activates Notch Signaling and Causes Chronic Lymphocytic Leukemia

Blood

2021/11/23

Dissecting Richter's syndrome in a multiplexed CRISPR-based mouse model reveals key changes in MYC, interferon and BCR signaling underlying transformation

Blood

2021/11/23

Risk factors associated with deep vein thrombosis in COVID‐19 patients

MedComm

2021/6

A hotspot mutation in transcription factor IKZF3 drives B cell neoplasia via transcriptional dysregulation

Cancer Cell

2021/3/8

La mutation recurrente IKZF3 L162R induit la surexpression de genes de la voie du BCR et de NF-kB dans un nouveau modele murin de LLC.

2020/3/20

See List of Professors in Shanye Yin University(Harvard University)